Alexei Bogdanov to Protein Kinase Inhibitors
This is a "connection" page, showing publications Alexei Bogdanov has written about Protein Kinase Inhibitors.
Connection Strength
0.476
-
Moiseenko F, Stroyakovskiy D, Levchenko E, Fedyanin M, Gabina A, Oganesian A, Belukhin S, Stepanova M, Stepanova E, Artemyeva E, Myslik A, Volkov N, Bogdanov A, Shuginova T, Kryukov K, Kheinshtein V, Allakhverdiev A, Zaberegniy I, Akhmadiyarova Y, Popov M, Danilova A, Sehniaidze D, Savelov N, Levchenko N, Slugin E, Lopushanskaya O, Kuligina E, Aleksakhina S, Iyevleva A, Ivantsov A, Moiseyenko V, Imyanitov E. Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR-Mutated Locally Advanced or Metastatic Lung Cancer. Int J Cancer. 2026 Nov 01; 159(9):2244-2261.
Score: 0.217
-
Kim YR, Yudina A, Figueiredo J, Reichardt W, Hu-Lowe D, Petrovsky A, Kang HW, Torres D, Mahmood U, Weissleder R, Bogdanov AA. Detection of early antiangiogenic effects in human colon adenocarcinoma xenografts: in vivo changes of tumor blood volume in response to experimental VEGFR tyrosine kinase inhibitor. Cancer Res. 2005 Oct 15; 65(20):9253-60.
Score: 0.208
-
Reichardt W, Hu-Lowe D, Torres D, Weissleder R, Bogdanov A. Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model. Neoplasia. 2005 Sep; 7(9):847-53.
Score: 0.051